diabetes
Europe grants Eperzan licence
March 27, 2014Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly
The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …
CHMP recommends Jardiance
March 24, 2014Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly
Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …
Sun Pharma comes under FDA import alert
March 17, 2014Manufacturing and Production Sun Pharma, diabetes, gabapentin, manufacturing, metformin, recall
The reputation of India’s pharma sector has been dealt a further blow after yet another drugmaker was placed under an …
Manufacturing hitches cited for Lilly/BI drug rejection
March 6, 2014Manufacturing and Production, Sales and Marketing Boehringer, FDA, diabetes, lilly, manufacturing
The FDA has refused to approve a new diabetes treatment from Lilly and its partner Boehringer Ingelheim due to ongoing …
AstraZeneca ‘simplifies decision-making’
February 4, 2014Sales and Marketing AstraZeneca, BMS, Byetta, Forxiga, Onglyza, diabetes
AstraZeneca has completed its $4.3 billion acquisition of Bristol-Myers Squibb’s diabetes business, giving the company control over several big-name brands …
BMS revenue drops in 2013
January 27, 2014Sales and Marketing AZ, BMS, Yervoy, diabetes, hep C, q4
Bristol-Myers’ Squibb’s revenue has fallen 7% year-on-year to $16.4 billion during 2013. Turnover rose 6% to $4.4 billion in the …
Google to use contact lens as diabetes monitor
January 17, 2014Medical Communications, Sales and Marketing calico, contact, diabetes, google, lens
Google is developing a new type of contact lens designed to help patients with diabetes measure their blood sugar levels. …
FDA approves Farxiga
January 10, 2014Sales and Marketing AstraZeneca, BMS, FDA, Forxiga, diabetes
The FDA has approved Farxiga, the diabetes treatment developed by AstraZeneca and Bristol-Myers Squibb as part of their soon-to-be-defunct diabetes …
BMS sells diabetes stake to partner AstraZeneca
December 19, 2013Sales and Marketing AstraZeneca, BMS, Forxiga, Onglyza, diabetes, komboglyze
AstraZeneca will buy out Bristol-Myers Squibb’s stake in its diabetes alliance in a potential $4.3 billion deal. AZ will pay …
Merck develops diabetes game
December 17, 2013Medical Communications, Sales and Marketing Gamification, Merck, ayogo, diabetes, type 2
Merck has announced it is working with digital health specialist Ayogo to develop a new game aimed at helping type …
Wii Fit Plus benefits patients with diabetes
December 10, 2013Medical Communications, Sales and Marketing bmc, diabetes, games, type 2, wii fit plus
A study says using interactive games through Nintendo’s Wii console helped type 2 diabetics to control their disease and improve …
New insulin scores for Sanofi
December 5, 2013Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300
Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …
FDA U-turn on Avandia
November 26, 2013Sales and Marketing Avandia, CDER, FDA, GSK, diabetes, nissen, type 2
The FDA has delivered a shock verdict that the stringent restrictions on GlaxoSmithKline’s diabetes medicine Avandia should be lifted, despite …
New chief executive for the International Diabetes Federation
November 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing diabetes, petra wilson
The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …
BMS abandons hep C, diabetes and neuroscience
November 11, 2013Sales and Marketing BMS, HIV, diabetes, hep C
Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …
Latest content
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner
